Article Information
History
- August 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Runzhe Chen1,2,#,
- Jun Li2,#,
- Junya Fujimoto3,
- Xin Hu2,
- Kelly Quek1,
- Ming Tang2,
- Akash Mitra2,
- Carmen Behrens1,
- Chi-Wan Chow3,
- Peixin Jiang1,
- Latasha D. Little2,
- Curtis Gumbs2,
- Xingzhi Song2,
- Jianhua Zhang2,
- Dongfeng Tan4,
- John V. Heymach1,
- Ignacio Wistuba3,
- P. Andrew Futreal2,
- Don L. Gibbons1,*,
- Lauren A. Byers1,*,
- Jianjun Zhang1,2,* and
- Alexandre Reuben1,*
- 1Department of Thoracic/Head and Neck Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
- 2Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
- 3Department of Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
- 4Department of Pathology, the University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
- ↵*Correspondence: dlgibbon{at}mdanderson.org (D.L.G.), lbyers{at}mdanderson.org (L.A.B.), jzhang20{at}mdanderson.org (J.J.Z.), areuben{at}mdanderson.org (A.R.)
Posted August 04, 2021.
Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma
